Karin Malmqvist

Regression of left ventricular hypertrophy in human hypertension with irbesartan

Karin Malmqvist, Thomas Kahan, Magnus Edner et al. · Journal of Hypertension · 2001 · 178 citations

Medicine, Cardiology, Pharmacology +17

Myocardial infarction with normal coronary arteries is common and associated with normal findings on cardiovascular magnetic resonance imaging: results from the <scp>S</scp>tockholm <scp>M</scp>yocardial <scp>I</scp>nfarction with <scp>N</scp>ormal <scp>C</scp>oronaries study

Olov Collste, Peder Sörensson, Mats Frick et al. · Journal of Internal Medicine · 2012 · 147 citations · Full text

Medicine, Cardiology, Clinical Sciences +14

Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin II receptor type 1 antagonist treatment in hypertensive patients

Lisa Kurland, Håkan Melhus, Julia Karlsson et al. · Journal of Hypertension · 2001 · 124 citations

Medicine, Cardiology, Pharmacology +17

Myocardial fibrosis and diastolic dysfunction in patients with hypertension: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA)

Richard Müller-Brunotte, Thomas Kahan, Begoña López et al. · Journal of Hypertension · 2007 · 107 citations

Medicine, Cardiology, Pharmacotherapy +17

The CYP2C9 genotype predicts the blood pressure response to irbesartan: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial

Pär Hallberg, Julia Karlsson, Lisa Kurland et al. · Journal of Hypertension · 2002 · 89 citations

Medicine, Cardiology, Pharmacology +17